Quality of life, Survival, COmorbidities, and Pharmacoeconomics in Elderly patients with Acute Myeloid Leukemia
Recruiting
- Conditions
- Leukeamia10024324Bloodcancer
- Registration Number
- NL-OMON53259
- Lead Sponsor
- Medisch Centrum Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
• Patient is diagnosed with de novo AML [ICD-10 = C92]
• Patient is treated in the Medical Centre Leeuwarden
• Age upon diagnosis >= 65 years
• Patient is classified as *ineligible for intensive chemotherapy* by the list
1 of the Ferrara criteria or by consideration from the practising haematologist
• Patient receives treatment in the form of a HMA combination regimen
• Patient provides a signed Informed Consent Form
Exclusion Criteria
• Bonemarrow analysis did not confirm AML
• Patients diagnosed with APL (t(15;17), WHO 2016) [ICD-10 = C92.4]
• Patients diagnosed with AMML (AML M4 / AML-M4eos) [ICD-10 = C92.5]
• Patients diagnosed with AMBL/AMCL (AML M5 / M5a / M5b) [ICD-10 = C93]
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method